Asymmetric synthesis of boc-N-methyl-p-benzoyl-phenylalanine. Preparation of a photoreactive antagonist of substance P

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 11, 1998, Pages 1369-1374

  Karoyan, Philippe ^a   Sagan, Sandrine ^a   Clodic, Gil ^a   Lavielle, Solange ^a   Chassaing, Gérard ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 BENZOYL N METHYLPHENYLALANINE; NEUROKININ 1 RECEPTOR; SUBSTANCE P; SUBSTANCE P ANTAGONIST; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; BINDING AFFINITY; DRUG BINDING SITE; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; OPTICAL ROTATION; PHOTOAFFINITY LABELING; PHOTOREACTIVITY; RECEPTOR BLOCKING; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

ALKYLATION; ANIMALS; BIOTIN; CHO CELLS; CRICETINAE; CYCLIC AMP; HUMANS; MOLECULAR CONFORMATION; PHENYLALANINE; PHOTOCHEMISTRY; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTANCE P;

EID: 0032474573     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00219-4     Document Type: Article

References (32)

1. 1. Ward, P.; Ewan, G.B.; Jordan, C.C.; Ireland, S.J.; Hagan, R.M.; Brown, J.R. J. Med. Chem. 1990, 33, 1848.
2. 2. Lavielle, S.; Brunissen, A.; Carruette, A.; Garret, C.; Chassaing, G. Eur. J. Pharmacol. 1994, 258, 273
3. 3. Kotzyba-Hibert, F. ; Kapfer, I. ; Goeldner, M. Angew. Chem. Ed. Engl. 1995, 34, 1296.
4. 4. Oppolzer, W.; Moretti, R.; Thomi, S. Tetrahedron Lett. 1989, 30, 6009.
5. 5. Oppolzer, W.; Moretti, R.; Zhou, C. Helv. Chim. Acta. 1994, 77, 2363.
6. 6. (a) Josien, H.; Martin, A.; Chassaing, G. Tetrahedron Lett. 1991, 30, 6547.
7. (b) Josien, H.; Chassaing, G. Tetrahedron Asymmetry 1992, 3, 1351.
8. 7. Ayoub, M.; Chassaing, G.; Loffet, A.; Lavielle, S. Tetrahedron Lett. 1995, 23, 4069.
9. 8. Girault, S. PhD Thesis, Université Pierre et Marie Curie, Paris, France , 1996.
10. 9. (a) Groeger, U.; Drauz; K.; Klenk, H. Angew.Chem.Int., Ed.Engl. 1992, 31, 195.
11. (b) mcdermott, J. R.; Benoiton, N. L. Can. J. Chem. 1973, 51, 1915.
12. (c) Cheung, S. T.; Benoiton, N. L. Can. J. Chem. 1977, 55, 906.
13. (d) Xue, C-B.; Degrado, W. F. P.Y. Tetrahedron Lett. 1995, 36, 55.
14. (e) Vilkas, E.; Lederer, E.; Thomi, S. Tetrahedron Lett. 1968, 26, 3089.
15. (f) Agarwal, K. L.; Kenner, G.W.; Scheppard, R.,.S. J. Amer. Chem. Soc. 1969, 91, 3096.
16. (g) Marino, G.; Valente, L.; Johnstone, R.A.W.; Mohammedi-Tabrizi, F. J. C. S. Chem. Comm. 1972, 357.
17. (h) 10. Shuman, R. T.; Smithwick, E. L.; Frederickson, R. C. A.; Gesellchen, P.D. Peptides: Proceedings of the 7th American Peptide Symposium ; Rich, D.; Gross, E., Eds.; Pierce Chemical Co. 1981, 617.
18. (i) Olsen, R. K. J. Org. Chem. 1970, 35, 6.
19. (j) Calmes, M.; Daunis, J.; Elyacoubi, R.; Jacquier, R. Tetrahedron: Asymmetry 1992, 3, 1351.
20. (k) Williams, R.M. Synthesis of Optically Active α-Amino Acids, Pergamon, Oxford 1989.
21. (l) Duthaler, R. D. Tetrahedron 1994, 50, 1539.
22. (m) Freidinger, R. M.; Hinkle, J.S.; Perlow, D.S.; Arison, B.H. J. Org. Chem. 1983, 48, 77.
23. (n) Pandey, G.; Reddy, P.Y.; Das, P. Tetrahedron Lett. 1996, 37', 3175.
24. -6M), according to structure-activity relationship (see references 1 and 2).
25. 5 : C, 66.92 ; H, 6.52 ; N, 3.65 ; found : C, 66.95 ; H, 6.54 ; N, 3.71.
26. 12. Girault, S.; Sagan, S.; Bolbach, G.; Lavielle, S.; Chassaing, G. Eur. J. Biochem. 1996, 240, 215.
27. 14 of the remaining amino group after deprotection of Boc-DPro onto the resin. Diketopiperazine formation was speculated since after Boc deprotection the original substitution has dropped. The best results were obtained after activation of a large excess of Boc-D-Pro with DCC. Even with such a procedure the substitution decreased from 0.68 mmol/g of resin (starting MBHA-resin) to an average of 0.35 - 0.45 mmol/g.
28. 14. Gisin, B.F. Anal.Chem.Acta 1972, 58, 248.
29. 19S, 1951.97
30. 16. (a) Sagan, S.; Chassaing, G.; Pradier, L.; Lavielle, S. J. Pharm. Exp. Ther.1996, 276, 1039.
31. (b) Sagan, S.; Beaujouan, J.-C.; Torrens, Y.; Saffroy, M.; Chassaing, G.; Glowinski, J.; Lavielle, S. Mol. Pharmacol. 1997, 52, 120.
32. 17. Snider, R.M.; Constantine, J.W.; Lowe III, J.A.; Longo, K.P.; Lebel, W.S.; Woody, H.A.; Drodza, S.E.; Desai, M.C.; Vinick, F.J.; Spencer, R.W.; Hess, H.-J. Science 1991, 251, 435.